Journey Medical (DERM) Net Margin (2020 - 2025)
Historic Net Margin for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 13.13%.
- Journey Medical's Net Margin rose 32100.0% to 13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.48%, marking a year-over-year increase of 172600.0%. This contributed to the annual value of 26.14% for FY2024, which is 212700.0% down from last year.
- Per Journey Medical's latest filing, its Net Margin stood at 13.13% for Q3 2025, which was up 32100.0% from 25.29% recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Net Margin peaked at 48.61% during Q3 2023, and registered a low of 124.17% during Q4 2021.
- In the last 5 years, Journey Medical's Net Margin had a median value of 31.0% in 2025 and averaged 37.05%.
- Its Net Margin has fluctuated over the past 5 years, first tumbled by -1403100bps in 2021, then soared by 1111600bps in 2023.
- Over the past 5 years, Journey Medical's Net Margin (Quarter) stood at 124.17% in 2021, then soared by 46bps to 66.65% in 2022, then soared by 79bps to 14.05% in 2023, then soared by 183bps to 11.62% in 2024, then crashed by -213bps to 13.13% in 2025.
- Its Net Margin stands at 13.13% for Q3 2025, versus 25.29% for Q2 2025 and 31.0% for Q1 2025.